| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2000374 | 重组全人源抗RANKL单克隆抗体注射液 | denosumab | Injection | Biological Products(3.3) | New Drug Application | 2020-12-23 | 广东安普泽生物医药股份有限公司 | Annpo Biotechnology Inc | In Review | 2020-12-22 | view |